Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,755 INR | -0.72% | +3.79% | +6.87% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.87% | 2.76B | |
-22.94% | 7.77B | |
+76.07% | 4.51B | |
-2.63% | 2.67B | |
-49.74% | 2.09B | |
-18.85% | 1.72B | |
-19.40% | 1.49B | |
+20.88% | 1.22B | |
-45.82% | 1.12B | |
+20.68% | 1.05B |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q3 2024 Earnings Call, Feb 01, 2024